14th May 2021 09:27
(Alliance News) - Physiomics PLC on Friday said it has been awarded a further contract by existing client Merck KGaA that it expects to be completed over the next two to three months.
The Oxford, England-based tumor technology firm said the contract follows on from and is additional to the initial tranche of projects with Merck announced in December 2020, with a value of GBP270,000, intended to be completed in the first six to eight months of 2021.
Physiomics shares were trading 11% higher in London on Friday morning at 6.65 pence each.
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Physiomics